Cargando…
Serious Adverse Events Among SPRINT Trial Participants Taking Statins at Baseline
BACKGROUND: Real-world evidence of statin side effects is potentially biased because statin use is neither randomized nor unblinded. An innovative study design can mitigate these biases. For example, in the recent ASCOT-LLA trial, patient-reported adverse events such as muscle pain and weakness were...
Autor principal: | Huesch, Marco D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694426/ https://www.ncbi.nlm.nih.gov/pubmed/29058304 http://dx.doi.org/10.1007/s40268-017-0213-9 |
Ejemplares similares
-
Associations of High‐Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT
por: Ascher, Simon B., et al.
Publicado: (2022) -
Baseline characteristics predicting clinical outcomes and serious adverse events in middle-aged hypertensive women: a subanalysis of the SPRINT in women aged <65 years
por: AYDIN, Volkan, et al.
Publicado: (2020) -
Personalized prediction of adverse heart and kidney events using baseline and longitudinal data from SPRINT and ACCORD
por: Dinstag, Gal, et al.
Publicado: (2019) -
Signal detection to identify serious adverse events (neuropsychiatric events) in travelers taking mefloquine for chemoprophylaxis of malaria
por: Naing, Cho, et al.
Publicado: (2012) -
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients: Nivolumab-related serious/fatal adverse events
por: Zhao, Bin, et al.
Publicado: (2018)